Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 9, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Reiterated (AVDL) at Strong Buy and Held Target at $22 on, May 9th, 2024
Ami Fadia of Needham, Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $22 on, May 9th, 2024.
Ami has made no other calls on AVDL in the last 4 months.
There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ami
- David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $23 on, Tuesday, March 5th, 2024
- Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $29 on, Tuesday, March 5th, 2024
- Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $21 on, Tuesday, February 6th, 2024
